title: [Treatment of metastatic melanoma with BRAF inhibitors].
authors.affiliation: Klinik und Poliklinik für Dermatologie, Universität Regensburg, Regensburg, Deutschland. christian.hafner@klinik.uni-regensburg.de
authors.forename: C
authors.initials: C
authors.lastname: Hafner
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic; D004252:DNA Mutational Analysis; D007211:Indoles / Q000009:adverse effects / Q000627:therapeutic use*; D008545:Melanoma / Q000188:drug therapy* / Q000235:genetics* / Q000556:secondary*; D048493:Proto-Oncogene Proteins B-raf / Q000037:antagonists & inhibitors* / Q000235:genetics; D015398:Signal Transduction / Q000235:genetics; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D013449:Sulfonamides / Q000009:adverse effects / Q000627:therapeutic use*; D000077484:Vemurafenib
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D013449:Sulfonamides; D000077484:Vemurafenib; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf